These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1471705)

  • 1. Increased bioactive luteinizing hormone levels in postmenopausal women with endometrial cancer.
    Nagamani M; Doherty MG; Smith ER; Chandrasekhar Y
    Am J Obstet Gynecol; 1992 Dec; 167(6):1825-30. PubMed ID: 1471705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women.
    Santoro N; Banwell T; Tortoriello D; Lieman H; Adel T; Skurnick J
    Am J Obstet Gynecol; 1998 Apr; 178(4):732-41. PubMed ID: 9579435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of luteinizing and follicle-stimulating hormone pulsatility in menopausal women: correlation with plasma testosterone level and vasomotor instability episodes.
    Fossum GT; Greep N; Kletzky OA
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):795-800. PubMed ID: 7573246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of secretion of bioactive luteinizing hormone in man.
    Dufau ML; Veldhuis JD; Fraioli F; Johnson ML; Beitins IZ
    J Clin Endocrinol Metab; 1983 Nov; 57(5):993-1000. PubMed ID: 6619273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
    Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
    J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
    Fabbri A; Jannini EA; Ulisse S; Gnessi L; Moretti C; Frajese G; Isidori A
    J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man.
    Veldhuis JD; Rogol AD; Johnson ML
    J Clin Invest; 1983 Dec; 72(6):2031-40. PubMed ID: 6315775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
    Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diurnal variations and temporal coupling of bioactive and immunoactive luteinizing hormone, prolactin, testosterone and 17-beta-estradiol in adult men.
    Juneja HS; Karanth S; Dutt A; Parte P; Meherjee P
    Horm Res; 1991; 35(3-4):89-94. PubMed ID: 1806473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologically active luteinizing hormone is secreted in episodic pulsations that vary in relation to stage of the menstrual cycle.
    Veldhuis JD; Beitins IZ; Johnson ML; Serabian MA; Dufau ML
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1050-8. PubMed ID: 6725507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women.
    Matikainen T; Ding YQ; Vergara M; Huhtaniemi I; Couzinet B; Schaison G
    J Clin Endocrinol Metab; 1992 Sep; 75(3):820-5. PubMed ID: 1517372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen regulates the gonadotropin-releasing hormone-stimulated secretion of biologically active luteinizing hormone.
    Urban RJ; Veldhuis JD; Dufau ML
    J Clin Endocrinol Metab; 1991 Mar; 72(3):660-8. PubMed ID: 1997520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive actions of a gonadotropin-releasing hormone antagonist on luteinizing hormone, follicle-stimulating hormone, and prolactin release in estrogen-deficient postmenopausal women.
    Urban RJ; Pavlou SN; Rivier JE; Vale WW; Dufau ML; Veldhuis JD
    Am J Obstet Gynecol; 1990 May; 162(5):1255-60. PubMed ID: 2111095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer.
    Nagamani M; Hannigan EV; Dinh TV; Stuart CA
    J Clin Endocrinol Metab; 1988 Jul; 67(1):144-8. PubMed ID: 3288650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
    Ausmanas MK; Tan DA; Jaisamrarn U; Tian XW; Holinka CF
    Climacteric; 2007 Oct; 10(5):427-37. PubMed ID: 17852146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The control of bioactive luteinizing hormone secretion in women with polycystic ovary syndrome.
    Lobo RA; Shoupe D; Chang SP; Campeau J
    Am J Obstet Gynecol; 1984 Feb; 148(4):423-8. PubMed ID: 6364811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute and chronic treatment with sodium valproate on gonadotropin hormone levels before menopause and during menopause].
    Spremović-Radjenović S; Popović V; Matijasević S; Erić-Marinković J
    Srp Arh Celok Lek; 1996; 124(7-8):179-83. PubMed ID: 9102843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic clearance of biologically active luteinizing hormone in man.
    Veldhuis JD; Fraioli F; Rogol AD; Dufau ML
    J Clin Invest; 1986 Apr; 77(4):1122-8. PubMed ID: 3958184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.